Cellular transformation by the MSP58 oncogene is inhibited by its physical interaction with the PTEN tumor suppressor

Koichi Okumura1, Mujun Zhao, Ronald A Depinho

  • 1Ludwig Institute for Cancer Research, San Diego Branch, University of California at San Diego, La Jolla, CA 92093-0660, USA.

Insights

The PTEN protein

Area of Science:

  • Oncogenic signaling and tumor suppression.
  • Molecular and cellular biology.
  • Protein-protein interactions in cancer.

Background:

  • PTEN (phosphatase and tensin homologue) is a crucial tumor suppressor.
  • The C-terminal region of PTEN is vital for protein stability and is frequently mutated in cancers.
  • The oncogenic protein MSP58 promotes cellular transformation.

Purpose of the Study:

  • To investigate the interaction between the PTEN C-terminal domain and the oncogenic MSP58 protein.
  • To determine the role of this interaction in cellular transformation.
  • To elucidate the functional significance of the PTEN C-terminal region beyond its catalytic activity.

Main Methods:

  • Co-immunoprecipitation assays to confirm physical interaction between PTEN and MSP58.
  • Cell transformation assays using mouse embryo fibroblasts (MEFs) with varying PTEN and MSP58 expression.
  • Site-directed mutagenesis to analyze the role of specific PTEN residues (e.g., Thr-366) and catalytic activity (G129R mutant).

Main Results:

  • The PTEN C-terminal domain directly interacts with the forkhead-associated domain of MSP58, requiring PTEN Thr-366.
  • Wild-type PTEN significantly inhibits MSP58-induced cellular transformation in Pten-/- MEFs.
  • A PTEN mutant (T366A) unable to interact with MSP58 failed to suppress transformation, indicating the interaction is critical.
  • A catalytically inactive PTEN mutant (G129R) retained the ability to suppress MSP58 oncogenicity, highlighting a non-catalytic function.

Conclusions:

  • The PTEN C-terminal region possesses a previously unrecognized function in suppressing cellular transformation.
  • This function is mediated through direct physical interaction with the oncogenic protein MSP58.
  • PTEN's role in cancer suppression involves both its catalytic activity and its C-terminal domain's interaction capabilities.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...